Topical  ||| S:0 E:8 ||| NNP
Review ||| S:8 E:14 ||| NNP
:  ||| S:14 E:16 ||| :
ADHD  ||| S:16 E:21 ||| NNP
and  ||| S:21 E:25 ||| CC
Health-Risk  ||| S:25 E:37 ||| NNP
Behaviors ||| S:37 E:46 ||| NNP
:  ||| S:46 E:48 ||| :
Toward  ||| S:48 E:55 ||| NNP
Prevention  ||| S:55 E:66 ||| NNP
and  ||| S:66 E:70 ||| CC
Health  ||| S:70 E:77 ||| NNP
Promotion  ||| S:77 E:87 ||| NNP
Across  ||| S:87 E:94 ||| IN
the  ||| S:94 E:98 ||| DT
lifespan ||| S:98 E:106 ||| NN
,  ||| S:106 E:108 ||| ,
attention  ||| S:108 E:118 ||| NN
deficit ||| S:118 E:125 ||| NN
/ ||| S:125 E:126 ||| FW
hyperactivity  ||| S:126 E:140 ||| FW
disorder  ||| S:140 E:149 ||| FW
( ||| S:149 E:150 ||| -LRB-
ADHD ||| S:150 E:154 ||| NNP
)  ||| S:154 E:156 ||| -RRB-
is  ||| S:156 E:159 ||| VBZ
associated  ||| S:159 E:170 ||| VBN
with  ||| S:170 E:175 ||| IN
increased  ||| S:175 E:185 ||| JJ
health  ||| S:185 E:192 ||| NN
risk  ||| S:192 E:197 ||| NN
behaviors  ||| S:197 E:207 ||| VBZ
including  ||| S:207 E:217 ||| VBG
substance  ||| S:217 E:227 ||| NN
abuse ||| S:227 E:232 ||| NN
,  ||| S:232 E:234 ||| ,
binge  ||| S:234 E:240 ||| NN
eating  ||| S:240 E:247 ||| NN
and  ||| S:247 E:251 ||| CC
obesity ||| S:251 E:258 ||| NN
,  ||| S:258 E:260 ||| ,
and  ||| S:260 E:264 ||| CC
unsafe  ||| S:264 E:271 ||| JJ
sexual  ||| S:271 E:278 ||| JJ
behavior ||| S:278 E:286 ||| NN
.  ||| S:286 E:288 ||| .
These  ||| S:288 E:294 ||| DT
risks  ||| S:294 E:300 ||| NNS
are  ||| S:300 E:304 ||| VBP
directly  ||| S:304 E:313 ||| RB
linked  ||| S:313 E:320 ||| VBN
to  ||| S:320 E:323 ||| TO
the  ||| S:323 E:327 ||| DT
neurocognitive  ||| S:327 E:342 ||| JJ
deficits  ||| S:342 E:351 ||| NNS
associated  ||| S:351 E:362 ||| VBN
with  ||| S:362 E:367 ||| IN
ADHD ||| S:367 E:371 ||| NNP
,  ||| S:371 E:373 ||| ,
and  ||| S:373 E:377 ||| CC
are  ||| S:377 E:381 ||| VBP
also  ||| S:381 E:386 ||| RB
mediated  ||| S:386 E:395 ||| VBN
by  ||| S:395 E:398 ||| IN
the  ||| S:398 E:402 ||| DT
cascade  ||| S:402 E:410 ||| NN
of  ||| S:410 E:413 ||| IN
psychosocial  ||| S:413 E:426 ||| JJ
impairments  ||| S:426 E:438 ||| NN
and  ||| S:438 E:442 ||| CC
stressors  ||| S:442 E:452 ||| NNS
caused  ||| S:452 E:459 ||| VBN
by  ||| S:459 E:462 ||| IN
ADHD  ||| S:462 E:467 ||| NNP
across  ||| S:467 E:474 ||| IN
development ||| S:474 E:485 ||| NN
.  ||| S:485 E:487 ||| .
However ||| S:487 E:494 ||| RB
,  ||| S:494 E:496 ||| ,
little  ||| S:496 E:503 ||| RB
is  ||| S:503 E:506 ||| VBZ
known  ||| S:506 E:512 ||| VBN
about  ||| S:512 E:518 ||| IN
optimal  ||| S:518 E:526 ||| JJ
approaches  ||| S:526 E:537 ||| NNS
to  ||| S:537 E:540 ||| TO
improve  ||| S:540 E:548 ||| VB
health  ||| S:548 E:555 ||| NN
outcomes  ||| S:555 E:564 ||| NNS
in  ||| S:564 E:567 ||| IN
this  ||| S:567 E:572 ||| DT
high-risk  ||| S:572 E:582 ||| JJ
population ||| S:582 E:592 ||| NN
.  ||| S:592 E:594 ||| .
This  ||| S:594 E:599 ||| DT
topical  ||| S:599 E:607 ||| JJ
review  ||| S:607 E:614 ||| NN
provides  ||| S:614 E:623 ||| VBZ
an  ||| S:623 E:626 ||| DT
overview  ||| S:626 E:635 ||| NN
of  ||| S:635 E:638 ||| IN
health  ||| S:638 E:645 ||| NN
risks  ||| S:645 E:651 ||| NNS
associated  ||| S:651 E:662 ||| VBN
with  ||| S:662 E:667 ||| IN
ADHD  ||| S:667 E:672 ||| NNP
and  ||| S:672 E:676 ||| CC
the  ||| S:676 E:680 ||| DT
limited  ||| S:680 E:688 ||| JJ
existing  ||| S:688 E:697 ||| JJ
research  ||| S:697 E:706 ||| NN
relevant  ||| S:706 E:715 ||| JJ
to  ||| S:715 E:718 ||| TO
health  ||| S:718 E:725 ||| NN
promotion  ||| S:725 E:735 ||| NN
for  ||| S:735 E:739 ||| IN
children  ||| S:739 E:748 ||| NNS
and  ||| S:748 E:752 ||| CC
adolescents  ||| S:752 E:764 ||| NNS
with  ||| S:764 E:769 ||| IN
ADHD ||| S:769 E:773 ||| NNP
.  ||| S:773 E:775 ||| .
Future  ||| S:775 E:782 ||| JJ
research  ||| S:782 E:791 ||| NN
questions  ||| S:791 E:801 ||| NNS
and  ||| S:801 E:805 ||| CC
implications  ||| S:805 E:818 ||| NNS
for  ||| S:818 E:822 ||| IN
clinicians  ||| S:822 E:833 ||| NNS
are  ||| S:833 E:837 ||| VBP
also  ||| S:837 E:842 ||| RB
addressed-especially  ||| S:842 E:863 ||| JJ
how  ||| S:863 E:867 ||| WRB
psychologists  ||| S:867 E:881 ||| NNS
and  ||| S:881 E:885 ||| CC
medical  ||| S:885 E:893 ||| JJ
practitioners  ||| S:893 E:907 ||| NNS
may  ||| S:907 E:911 ||| MD
improve  ||| S:911 E:919 ||| VB
child  ||| S:919 E:925 ||| NN
health  ||| S:925 E:932 ||| NN
through  ||| S:932 E:940 ||| IN
early  ||| S:940 E:946 ||| JJ
screenings ||| S:946 E:956 ||| NNS
,  ||| S:956 E:958 ||| ,
increasing  ||| S:958 E:969 ||| VBG
medication  ||| S:969 E:980 ||| NN
adherence ||| S:980 E:989 ||| NN
,  ||| S:989 E:991 ||| ,
and  ||| S:991 E:995 ||| CC
treating  ||| S:995 E:1004 ||| VBG
psychosocial  ||| S:1004 E:1017 ||| JJ
impairments ||| S:1017 E:1028 ||| NN
.  ||| S:1028 E:1030 ||| .
